Home>>PtdIns-(3,5)-P2 (1,2-dipalmitoyl) (sodium salt)

PtdIns-(3,5)-P2 (1,2-dipalmitoyl) (sodium salt) (Synonyms: Phosphatidylinositol3,5diphosphate C16)

Catalog No.GC44757

The phosphatidylinositol (PtdIns) phosphates represent a small percentage of total membrane phospholipids.

Products are for research use only. Not for human use. We do not sell to patients.

PtdIns-(3,5)-P2 (1,2-dipalmitoyl) (sodium salt) Chemical Structure

Size Price Stock Qty
100μg
$87.00
In stock
500μg
$385.00
In stock
1mg
$686.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

The phosphatidylinositol (PtdIns) phosphates represent a small percentage of total membrane phospholipids. However, they play a critical role in the generation and transmission of cellular signals. Phosphatidylinositol (PtdIns)-(3,5)-P2 (1,2-dipalmitoyl) (sodium salt) is a synthetic analog of natural PtdIns featuring saturated C16:0 fatty acids at the sn-1 and sn-2 positions. The compound features the same inositol and diacylglycerol stereochemistry as that of the natural compound. PtdIns-(3,5)-P2 is rapidly synthesized from PtdIns-(3)-P1 in yeast when a PtdIns-(3)-P5-hydroxy kinase is activated during hyperosmotic conditions. PtdIns-(3,5)-P2 is also present in mammalian cells, such as monkey COS-7 cells, where a similar biosynthetic route has been demonstrated.

Reviews

Review for PtdIns-(3,5)-P2 (1,2-dipalmitoyl) (sodium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PtdIns-(3,5)-P2 (1,2-dipalmitoyl) (sodium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.